Clinical Trial Update: 5-Azacitidine in Low-risk Myelodysplastic Syndromes (MDSs) [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 study evaluating azacitidine in patients with low-risk myelodysplastic syndromes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• AZACITIDINE (AZACITIDINE)

Snippet

Sponsor: Università degli Studi di Brescia | Conditions: Myelodysplastic Syndrome | Phase 2 | Status: COMPLETED